A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
Links
(3) - ARTICLES
subject heading
openseadragon
Number of the records: 1
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.
